comparemela.com

Latest Breaking News On - Akero therapeutics inc - Page 1 : comparemela.com

AKRO INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP

SAN DIEGO, June 13, 2024 (GLOBE NEWSWIRE) The law firm of Robbins Geller Rudman & Dowd LLP announces that it has filed a class action lawsuit.

San-diego
California
United-states
Jennifern-caringal
Robbins-geller
Akero-therapeutics-inc
Us-food-drug-administration
Securities-exchange
Enron-corp
Nasdaq
Securities-class-action-services-top
Robbins-geller-rudman-dowd

AKERO THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: ...

AKERO THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: ...
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

Delaware
United-states
New-orleans
Louisiana
New-york
California
New-jersey
Lewis-kahn
Charlesc-foti-jr
Kahn-swick-foti
Nasdaq
Akero-therapeutics-inc

AKRO Investors Have Opportunity to Lead Akero Therapeutics,

NEW YORK, June 11, 2024 (GLOBE NEWSWIRE) WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Akero.

New-york
United-states
China
Chinese
Laurence-rosen
Phillip-kim
Nasdaq
Chinese-company
Twitter
Linkedin
Securities-class-action-services
Facebook

Akero Therapeutics, Inc. (NASDAQ:AKRO) Position Trimmed by Avidity Partners Management LP

Avidity Partners Management LP lowered its stake in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 68.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 235,000 shares of the company’s stock after selling 504,100 shares during the quarter. Avidity Partners Management LP […]

United-states
America
Jonathan-young
Canaccord-genuity-group
Wolfe-research
Nasdaq
Headlands-technologies
Akero-therapeutics-inc
Securities-exchange-commission
Orion-capital-management
Tower-research-capital
Quest-partners

Akero Therapeutics, Inc. (NASDAQ:AKRO) Position Trimmed by Avidity Partners Management LP

Avidity Partners Management LP lowered its stake in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 68.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 235,000 shares of the company’s stock after selling 504,100 shares during the quarter. Avidity Partners Management LP […]

United-states
America
Jonathan-young
Orion-capital-management
Quest-partners
Tower-research-capital
Securities-exchange-commission
Wolfe-research
Canaccord-genuity-group
Akero-therapeutics-inc
Headlands-technologies
Nasdaq

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.